264 related articles for article (PubMed ID: 14502678)
21. Successful management of drooling with botulinum toxin A in neurologically disabled children.
Ellies M; Rohrbach-Volland S; Arglebe C; Wilken B; Laskawi R; Hanefeld F
Neuropediatrics; 2002 Dec; 33(6):327-30. PubMed ID: 12571790
[TBL] [Abstract][Full Text] [Related]
22. Drooling: are botulinum toxin injections into the major salivary glands a good treatment option?
Nordgarden H; Østerhus I; Møystad A; Asten P; Johnsen UL; Storhaug K; Loven JØ
J Child Neurol; 2012 Apr; 27(4):458-64. PubMed ID: 21940695
[TBL] [Abstract][Full Text] [Related]
23. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.
Porte M; Chaléat-Valayer E; Patte K; D'Anjou MC; Boulay C; Laffont I
Eur J Paediatr Neurol; 2014 Nov; 18(6):649-57. PubMed ID: 24931915
[TBL] [Abstract][Full Text] [Related]
24. [Botulinum Toxin in Functional Hypersalivation--All about Dosage?].
Steffen A; Hasselbacher K; Brüggemann N; Heinrichs S; Schönweiler R; Wollenberg B
Laryngorhinootologie; 2015 Jun; 94(6):378-82. PubMed ID: 25437838
[TBL] [Abstract][Full Text] [Related]
25. The use of botulinum toxic injection to treat excessive drooling in children with neurological conditions.
Khan A; Pawar G
W V Med J; 2005; 101(6):258-60. PubMed ID: 16625812
[TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin in the treatment of sialorrhea.
Svetel M; Vasić M; Dragasević N; Pekmezović T; Petrović I; Kostić V
Vojnosanit Pregl; 2009 Jan; 66(1):9-12. PubMed ID: 19195257
[TBL] [Abstract][Full Text] [Related]
27. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy.
Suskind DL; Tilton A
Laryngoscope; 2002 Jan; 112(1):73-81. PubMed ID: 11802042
[TBL] [Abstract][Full Text] [Related]
28. Drooling in Parkinson's disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins.
Narayanaswami P; Geisbush T; Tarulli A; Raynor E; Gautam S; Tarsy D; Gronseth G
Parkinsonism Relat Disord; 2016 Sep; 30():73-7. PubMed ID: 27406786
[TBL] [Abstract][Full Text] [Related]
29. Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis.
Costa J; Rocha ML; Ferreira J; Evangelista T; Coelho M; de Carvalho M
J Neurol; 2008 Apr; 255(4):545-50. PubMed ID: 18283399
[TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin A as treatment for drooling saliva in PD.
Pal PK; Calne DB; Calne S; Tsui JK
Neurology; 2000 Jan; 54(1):244-7. PubMed ID: 10636161
[TBL] [Abstract][Full Text] [Related]
31. [Experimental and clinical investigations on the inhibition of secretion of the major salivary glands with botulinum toxin A].
Ellies M
Laryngorhinootologie; 2003 Oct; 82(10):713-4. PubMed ID: 14593570
[No Abstract] [Full Text] [Related]
32. Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease.
Melo A; Rodrigues B; Nóbrega AC
J Am Geriatr Soc; 2009 Jan; 57(1):180; author reply 180-1. PubMed ID: 19170803
[No Abstract] [Full Text] [Related]
33. Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study.
Hyson HC; Johnson AM; Jog MS
Mov Disord; 2002 Nov; 17(6):1318-20. PubMed ID: 12465075
[TBL] [Abstract][Full Text] [Related]
34. Qualitative and quantitative scintigraphy in sialorrhea before and after botulinum toxin injection.
Ribeiro LB; Xerez DR; Maliska C; de Souza SAL; Costa MMB
Laryngoscope; 2019 Nov; 129(11):2521-2526. PubMed ID: 30693525
[TBL] [Abstract][Full Text] [Related]
35. Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.
Young CA; Ellis C; Johnson J; Sathasivam S; Pih N
Cochrane Database Syst Rev; 2011 May; (5):CD006981. PubMed ID: 21563158
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of sialorrhea with botulinum toxin: an overview].
Hagenah J; Kahl KG; Steinlechner S; Lencer R; Klein C
Nervenarzt; 2005 Apr; 76(4):418-25. PubMed ID: 15448912
[TBL] [Abstract][Full Text] [Related]
37. Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview.
Petracca M; Guidubaldi A; Ricciardi L; Ialongo T; Del Grande A; Mulas D; Di Stasio E; Bentivoglio AR
Toxicon; 2015 Dec; 107(Pt A):129-40. PubMed ID: 26327120
[TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin type B for sialorrhea in children with cerebral palsy.
Reddihough D; Graham HK
Dev Med Child Neurol; 2011 Jun; 53(6):488-9. PubMed ID: 21501158
[No Abstract] [Full Text] [Related]
39. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms.
Møller E; Karlsborg M; Bardow A; Lykkeaa J; Nissen FH; Bakke M
Acta Odontol Scand; 2011 May; 69(3):151-7. PubMed ID: 21198339
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia.
Barbero P; Busso M; Tinivella M; Artusi CA; De Mercanti S; Cucci A; Veltri A; Avagnina P; Calvo A; Chio' A; Durelli L; Clerico M
J Neurol; 2015 Dec; 262(12):2662-7. PubMed ID: 26410746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
